Agonist Induced-Phosphorylation of Gα11 Protein Reduces Coupling to 5-HT2A Receptors
Authors:
- Katerina J. DamjanoskaKDKaterina J. Damjanoska
- Rakesh K. SinghRSRakesh K. Singh
- Gonzalo A. CarrascoGCGonzalo A. Carrasco
- Francisca GarciaFGFrancisca Garcia
- Angela J. GrippoAGAngela J. Grippo
- Michelle LandryMLMichelle Landry
- Nicole R. SullivanNSNicole R. Sullivan
- George BattagliaGBGeorge Battaglia
- Nancy A. MumaNMNancy A. Muma
- 1 October 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 323 (1) , 248-256
Abstract
We previously demonstrated that 24-h treatment with (–)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI) causes phosphorylation of Gα11 protein at serine 154 and that this phosphorylation causes desensitization of serotonin (5-HT) 2A receptor signaling in A1A1v cells (Shi et al., 2007). We now report that treatment of A1A1v cells with DOI for 24 h produces a greater reduction in the Bmax of [125I](±)-DOI-labeled high-affinity binding sites (46%) than the reduction of [3H]ketanserin binding sites (25%). Although the KD values are not altered, there is a smaller amount of GTPγS [guanosine 5′-3-O-(thio)triphosphate]-sensitive [125I](±)-DOI binding in DOI-treated cells. These results suggest that DOI treatment causes down-regulation of 5-HT2A receptors and reductions in G protein-coupled 5-HT2A receptors. In contrast, in cells transfected with the phosphorylation state mimic Gα11S154D, GTPγS-sensitive [125I](±)-DOI binding was decreased by 48%; however, there was no significant difference in the KD and Bmax values of [125I](±)-DOI-labeled receptors. The receptor binding experiments suggest that phosphorylation of Gα11 on serine 154 reduces coupling of 5-HT2A receptors, whereas DOI causes down-regulation of 5-HT2A receptors in addition to the phosphorylation-induced uncoupling of Gα11 to 5-HT2A receptors. To determine whether DOI increases phosphorylation of Gαq/11 protein in vivo, rats were treated with 1 mg/kg/day DOI or saline for 1 to 7 days. Seven days of DOI treatment significantly decreased phospholipase C activity stimulated by an Emax concentration of 5-HT by 40% and increased phosphorylation of Gαq/11 proteins by 51% in the frontal cortex. These data suggest that DOI causes phosphorylation of Gαq/11 in vivo and could thereby contribute to the desensitization of 5-HT2A receptors.Keywords
This publication has 38 references indexed in Scilit:
- Loss of association between activated Gαq and Gβγ disrupts receptor-dependent and receptor-independent signalingCellular Signalling, 2005
- Agonist-Induced Serotonin 2A Receptor Desensitization in the Rat Frontal Cortex and HypothalamusThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Chronic Fluoxetine Differentially Affects 5-Hydroxytryptamine2A Receptor Signaling in Frontal Cortex, Oxytocin- and Corticotropin-Releasing Factor-Containing Neurons in Rat Paraventricular NucleusThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Internalization and recycling of 5-HT 2A receptors activated by serotonin and protein kinase C-mediated mechanismsProceedings of the National Academy of Sciences, 2002
- Regulation of 5-HT2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserinNeuropharmacology, 2000
- Agonist high and low affinity state ratios predict drug intrinsic activity and a revised Ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptorsSynapse, 1999
- Decreased frontal cortical serotonin2A receptors in schizophreniaSchizophrenia Research, 1996
- Do functional relationships exist between 5-HT1A and 5-HT2 receptors?Pharmacology Biochemistry and Behavior, 1990
- Serotonin2 agonist administration down-regulates rat brain serotonin2 receptorsLife Sciences, 1988
- Alpha1Adrenergic Receptors in the Porcine Pituitary Neurointermediate Lobe: Detection with [3H]KetanserinJournal of Receptor Research, 1984